These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2750648)
1. The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models. Luketich J; Friehling TD; O'Connor KM; Kowey PR Am Heart J; 1989 Aug; 118(2):265-71. PubMed ID: 2750648 [TBL] [Abstract][Full Text] [Related]
2. Ventricular tachyarrhythmias in rats with acute myocardial infarction involves activation of small-conductance Ca2+-activated K+ channels. Gui L; Bao Z; Jia Y; Qin X; Cheng ZJ; Zhu J; Chen QH Am J Physiol Heart Circ Physiol; 2013 Jan; 304(1):H118-30. PubMed ID: 23086994 [TBL] [Abstract][Full Text] [Related]
3. The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models. O'Connor KM; Friehling TD; Kowey PR Am Heart J; 1989 Apr; 117(4):848-53. PubMed ID: 2929400 [TBL] [Abstract][Full Text] [Related]
4. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart. Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111 [TBL] [Abstract][Full Text] [Related]
5. Influence of site of stimulation on measurement of ventricular vulnerability in the normal and ischemic feline heart. Kowey PR; Friehling TD; Wetstein L; O'Connor KM; Kelliher GJ Am J Cardiol; 1984 Aug; 54(3):421-3. PubMed ID: 6465027 [TBL] [Abstract][Full Text] [Related]
6. Arrhythmia inducibility and ventricular vulnerability in a chronic feline infarction model. Wetstein L; Mark R; Kelliher GJ; Friehling T; O'Connor KM; Kowey PR Am Heart J; 1985 Nov; 110(5):955-60. PubMed ID: 4061270 [TBL] [Abstract][Full Text] [Related]
7. Acute electrophysiologic effects and antiarrhythmic/antifibrillatory activity of intravenous amiodarone in a chronic feline infarction model. Marinchak RA; O'Connor KM; Friehling TD; Kowey PR J Cardiovasc Pharmacol; 1989 Sep; 14(3):389-95. PubMed ID: 2476617 [TBL] [Abstract][Full Text] [Related]
8. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model. Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration. Aupetit JF; Frassati D; Bui-Xuan B; Freysz M; Faucon G; Timour Q Cardiovasc Res; 1998 Mar; 37(3):646-55. PubMed ID: 9659448 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade. Kowey PR; Friechling TD; Sewter J; Wu Y; Sokil A; Paul J; Nocella J Circulation; 1991 Jun; 83(6):2067-75. PubMed ID: 1645624 [TBL] [Abstract][Full Text] [Related]
11. Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction. Adamson PB; Vanoli E; Hull SS; Foreman RD; Schwartz PJ Cardiovasc Res; 1998 Oct; 40(1):56-63. PubMed ID: 9876317 [TBL] [Abstract][Full Text] [Related]
12. Spontaneous and electrically induced ventricular arrhythmias during acute ischemia superimposed on 2 week old canine myocardial infarction. Garan H; McComb JM; Ruskin JN J Am Coll Cardiol; 1988 Mar; 11(3):603-11. PubMed ID: 3343465 [TBL] [Abstract][Full Text] [Related]
13. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing. Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629 [TBL] [Abstract][Full Text] [Related]
14. Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion. Pearle DL; Williford D; Gillis RA Am J Cardiol; 1978 Dec; 42(6):960-4. PubMed ID: 727146 [TBL] [Abstract][Full Text] [Related]
15. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Corbalan R; Verrier RL; Lown B Am Heart J; 1976 Aug; 92(2):223-30. PubMed ID: 941834 [TBL] [Abstract][Full Text] [Related]
18. Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Misier AR; Opthof T; van Hemel NM; Vermeulen JT; de Bakker JM; Defauw JJ; van Capelle FJ; Janse MJ Circulation; 1995 May; 91(10):2566-72. PubMed ID: 7743618 [TBL] [Abstract][Full Text] [Related]
19. Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heart. Raeder EA; Verrier RL; Lown B Am J Cardiol; 1982 Aug; 50(2):271-5. PubMed ID: 7102558 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic effects of left ventricular hypertrophy in the intact cat. Shechter JA; O'Connor KM; Friehling TD; Mark R; Uboh C; Kowey PR Am J Hypertens; 1989 Feb; 2(2 Pt 1):81-5. PubMed ID: 2521793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]